Kovarik J - Search Results

1

Pharmacokinetics and metabolism of cyclosporine A in 19 hemodialysis patients.

Küllinger B, Wolfram J, Hamilton G, Horzemsky M, Kovarik J, Woloszczuk W, Steiner G. Küllinger B, et al. Among authors: kovarik j. Transplant Proc. 1990 Aug;22(4):1702-5. Transplant Proc. 1990. PMID: 2202128 No abstract available.

2

Single-dose response kinetics of oral cyclosporine A: a critical reexamination.

Klauser R, Irschik H, Wolfram J, Woloszczuk W, Kovarik J. Klauser R, et al. Among authors: kovarik j. Transplant Proc. 1992 Dec;24(6):2610-3. Transplant Proc. 1992. PMID: 1465883 No abstract available.

3

Determination of cyclosporine by a competitive binding assay with cyclophilin.

Steiner G, Küllinger B, Mayer G, Jie Y, Leibl H, Kovarik J, Woloszczuk W. Steiner G, et al. Among authors: kovarik j. Clin Chem. 1991 Mar;37(3):403-10. Clin Chem. 1991. PMID: 2004448

4

Statistical and computer evaluation of the cytologic monitoring of kidney graft recipients in the immediate posttransplantation period.

Rasoul-Rockenshaub S, Kundi M, Kovarik J, Ullrich W, Popow T, Woloszczuk W. Rasoul-Rockenshaub S, et al. Among authors: kovarik j. Transplant Proc. 1988 Aug;20(4):629-31. Transplant Proc. 1988. PMID: 3043821 No abstract available.

5

Neoral--a new microemulsion formula of cyclosporine A: interpatient pharmacokinetic variability in renal transplant recipients.

Klauser R, Irschik H, Kletzmayr J, Sturm I, Brunner W, Woloszczuk W, Kovarik J. Klauser R, et al. Among authors: kovarik j. Transplant Proc. 1995 Dec;27(6):3427-9. Transplant Proc. 1995. PMID: 8540034 Clinical Trial. No abstract available.

6

Pharmacokinetic cyclosporine A profiles under long-term Neoral treatment in renal transplant recipients: does fat intake still matter?

Klauser RM, Irschik H, Kletzmayr J, Sturm I, Brunner W, Woloszczuk W, Kovarik J. Klauser RM, et al. Among authors: kovarik j. Transplant Proc. 1997 Nov;29(7):3137-40. doi: 10.1016/s0041-1345(97)00814-2. Transplant Proc. 1997. PMID: 9365698 No abstract available.

7

Evidence that sensitivity to cyclosporine is influenced by the HLA-DR phenotype of kidney graft recipients.

Zlabinger GJ, Kudlacek S, Pohanka E, Franz M, Hamilton G, Rosenmayr A, Kovarik J. Zlabinger GJ, et al. Among authors: kovarik j. Transplantation. 1992 Apr;53(4):758-62. doi: 10.1097/00007890-199204000-00010. Transplantation. 1992. PMID: 1566340

8

Interferon-gamma, neopterin, and interleukin-2 receptor levels in the serum of kidney transplant recipients.

Steiner G, Zlabinger G, Karamehic J, Pohanka E, Kovarik J, Woloszczuk W. Steiner G, et al. Among authors: kovarik j. Transplant Proc. 1990 Aug;22(4):1857-8. Transplant Proc. 1990. PMID: 2117813 No abstract available.

9

OKT3 monoclonal antibody treatment in renal transplant recipients--clinical experience in 49 patients.

Kovarik J, Zlabinger GJ, Wolfram J, Pecherstorfer M, Watschinger B, Traindl O, Pohanka E, Sonnleitner A, Ulrich W. Kovarik J, et al. Transplant Proc. 1989 Feb;21(1 Pt 2):1748-52. Transplant Proc. 1989. PMID: 2652572 No abstract available.

10

Insensitivity to cyclosporine may explain the HLA-DRw6 recipient effect.

Kudlacek S, Zlabinger GJ, Pohanka E, Hamilton G, Rosenmayr A, Kovarik J. Kudlacek S, et al. Among authors: kovarik j. Transpl Int. 1992;5 Suppl 1:S556-8. doi: 10.1007/978-3-642-77423-2_163. Transpl Int. 1992. PMID: 14621875

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

696 results

Search Page

Filters